European Journal of Cancer
Volume 46, Issue 5 , Pages 995-1005 , March 2010

Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-β-dependent mechanism in diffuse-type gastric cancer cells

  • Satoru Noda

      Affiliations

    • Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan
    • ,
  • Masakazu Yashiro

      Affiliations

    • Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan
    • Oncology Institute of Geriatrics and Medical Science, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan
    • Corresponding Author InformationCorresponding author: Address: Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. Tel.: +81 6 6645 3838; fax: +81 6 6646 6450.
    • ,
  • Takafumi Nshii

      Affiliations

    • Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan
    • ,
  • Kosei Hirakawa

      Affiliations

    • Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan

Received 22 December 2009 ,Accepted 6 January 2010.

References 

  1. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis. 2009;26(1):19–34
  2. Hockel M, Schlenger K, Hockel S, et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 1999;59(18):4525–4528
  3. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59(22):5830–5835
  4. Subarsky P, Hill RP. Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells. Clin Exp Metastasis. 2008;25(3):253–264
  5. Hockel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56(19):4509–4515
  6. Griffiths EA, Pritchard SA, Valentine HR, et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 2007;96(1):95–103
  7. Griffiths EA, Pritchard SA, Welch IM, et al. Is the hypoxia-inducible factor pathway important in gastric cancer?. Eur J Cancer. 2005;41(18):2792–2805
  8. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49
  9. Chen CY, Wu CW, Lo SS, et al. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology. 2002;49(45):874–877
  10. Ikeguchi M, Yamamoto O, Kaibara N. Management protocol for scirrhous gastric cancer. In Vivo. 2004;18(5):577–580
  11. Nakamura K, Yashiro M, Matsuoka T, et al. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer. Gastroenterology. 2006;131(5):1530–1541
  12. Yashiro M, Chung YS, Nishimura S, et al. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer. 1995;72(5):1200–1210
  13. Nishimura S, Chung YS, Yashiro M, et al. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer. 1996;74(9):1406–1412
  14. Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1, 297 patients with gastric carcinoma. Am J Surg. 1999;178(3):256–262
  15. Kizaka-Kondoh S, Itasaka S, Zeng L, et al. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Clin Cancer Res. 2009;15(10):3433–3441
  16. Matsuoka T, Yashiro M, Nishimura S, et al. Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma. Int J Mol Med. 2000;5(1):21–25
  17. Koyama T, Yashiro M, Inoue T, et al. TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. Int J Oncol. 2000;16(2):355–362
  18. Kawajiri H, Yashiro M, Shinto O, et al. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res. 2008;14(9):2850–2860
  19. Irigoyen M, Anso E, Salvo E, et al. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci. 2008;65(14):2244–2255
  20. Takemura S, Yashiro M, Sunami T, Tendo M, Hirakawa K. Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci. 2004;95(11):893–900
  21. Sekiguchi M, Sakakibara K, Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med. 1978;48(1):61–68
  22. Motoyama T, Hojo H, Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn. 1986;36(1):65–83
  23. Nakashio T, Narita T, Akiyama S, et al. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Int J Cancer. 1997;70(5):612–618
  24. Rohwer N, Welzel M, Daskalow K, et al. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res. 2008;68(24):10113–10120
  25. Spangenberg C, Lausch EU, Trost TM, et al. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. Cancer Res. 2006;66(7):3715–3725
  26. Kong F, Garcia AJ, Mould AP. Demonstration of catch bonds between an integrin and its ligand. J Cell Biol. 2009;185(7):1275–1284
  27. Ijichi H, Ikenoue T, Kato N, et al. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun. 2001;289(2):350–357
  28. Yamamoto M, Maehara Y, Sakaguchi Y, et al. Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer. 1996;77(8 Suppl.):1628–1633
  29. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732

PII: S0959-8049(10)00008-0

doi: 10.1016/j.ejca.2010.01.007

European Journal of Cancer
Volume 46, Issue 5 , Pages 995-1005 , March 2010

Article Tools

* Image Usage & Resolution